d-Penicillamine, a potent copper-chelating agent, is used in treating Wilson’s disease (hepatolenticular degeneration), an autosomal recessive genetic disorder caused by mutations in the ATP7B gene which results in abnormal copper metabolism and subsequent accumulation of copper in tissues, especially, the liver and brain (Lorincz 2010). The gene discussed is ATP7B; the disease is Wilson disease.